Annual report pursuant to Section 13 and 15(d)

Balance Sheets

v2.4.0.8
Balance Sheets (USD $)
Sep. 30, 2013
Sep. 30, 2012
CURRENT ASSETS    
Cash $ 5,122,895 $ 2,632,413
Prepaid expenses 45,350 218,242
Total Current Assets 5,168,245 2,850,655
EQUIPMENT, net 29,755 43,111
OTHER ASSETS    
Patent costs, net 545,865 623,654
TOTAL ASSETS 5,743,865 3,517,420
CURRENT LIABILITIES    
Accounts payable and accrued expenses 465,686 300,462
Notes payable 14,051 22,037
Derivative liabilities    768,696
Total Current Liabilities 479,737 1,091,195
TOTAL LIABILITIES 479,737 1,091,195
STOCKHOLDERS' EQUITY    
Preferred stock, Series B; 6,000,000 shares authorized, $0.0001 par value, 500,000 and 5,583,336 shares issued and outstanding, respectively 50 558
Common stock; 180,000,000 shares authorized, $0.0001 par value, 19,741,541 and 15,752,896 shares issued and outstanding, respectively 1,974 1,575
Additional paid-in capital 39,444,988 30,966,379
Stock subscription receivable    (11,891)
Accumulated deficit (21,628,748) (21,628,748)
Deficit accumulated during the development stage (12,554,136) (6,901,648)
Total Stockholders' Equity 5,264,128 2,426,225
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 5,743,865 $ 3,517,420